28.03.2019
- At a cost of $775 million, Bayer and Johnson & Johnson have agreed to settle claims by patients against the top-selling anticoagulant Xarelto out of court. The two drugmakers said...
19.01.2018
- A report from the US Food and Drug Administration (FDA) published in Pharmacoepidemiology & Drug Safety has confirmed the safety profile and effectiveness of the anticoagulant...
12.12.2017
- In the fourth of three lawsuits heard by US courts over the risks of the blockbuster blood thinner Xarelto to date, a jury in Philadelphia, Pennsylvania, last week ordered Bayer...
22.08.2017
- Germany’s Bayer and Johnson & Johnson (J&J) of the US have won the third of three lawsuits involving bleeding risks of the blockbuster blood thinner Xarelto, which was developed...
05.05.2017
- Bayer and Johnson & Johnson have won the first of around 18,000 lawsuits lawsuit being brought by US patients who claim the blood-thinning drug Xarelto caused their uncontrollable...
12.03.2015
- Bayer aims to achieve strong sales and earnings growth for its life science businesses in the coming years, CEO Marijn Dekkers said at the "Meet Management" investor conference in...
31.10.2014
- Buoyed by a strong performance in its Healthcare and CropScience businesses in the third quarter, Bayer has raised its forecast for full year 2014. CEO Marijn Dekkers said he...
16.10.2014
- Bayer soon may find itself regretting its decision to sell its plastics business and become a pure life science player. According to international press reports, the German group's...
